Abstract | OBJECTIVE: DESIGN: In vitro study. SETTING: University reproductive biology laboratories. PATIENT(S): None. INTERVENTION(S): MAIN OUTCOME MEASURE(S): Three functional progesterone response elements (PREs) in the VEGF promoter were identified by electrophoretic mobility-shift assay, and different constructs were created to assess each PRE. RESULT(S): In cells expressing hPRA or B, treatment with 10 nM R5020 or 100 nM medroxyprogesterone acetate statistically significantly increased luciferase activity (3.3- to 4.8-fold). Pretreatment with 100 nM RU486 blunted the effect of 10 nM R5020, resulting only in a slight, statistically nonsignificant increase in luciferase activity (1.3- to 1.7-fold). Although three different functional PREs could be identified, no single PRE accounted for the preponderance of the luciferase activity. Full VEGF promoter activation required all three PREs. CONCLUSION(S):
Progestins have a direct effect on VEGF gene transcription. However, hPR-mediated transcriptional regulation of the VEGF promoter is complex and cannot be localized to confined PRE sequences. Other response element motifs are likely to play a contributory role.
|
Authors | Michael D Mueller, Jean Louis Vigne, Elizabeth A Pritts, Victor Chao, Ekkehard Dreher, Robert N Taylor |
Journal | Fertility and sterility
(Fertil Steril)
Vol. 79
Issue 2
Pg. 386-92
(Feb 2003)
ISSN: 0015-0282 [Print] United States |
PMID | 12568850
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Endothelial Growth Factors
- Intercellular Signaling Peptides and Proteins
- Lymphokines
- Receptors, Progesterone
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
- Mifepristone
- Promegestone
- Medroxyprogesterone
|
Topics |
- Adenocarcinoma
(genetics)
- Endometrial Neoplasms
(genetics)
- Endothelial Growth Factors
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- Intercellular Signaling Peptides and Proteins
(genetics)
- Lymphokines
(genetics)
- Medroxyprogesterone
(pharmacology)
- Mifepristone
(pharmacology)
- Promegestone
(pharmacology)
- Receptors, Progesterone
(physiology)
- Transcription, Genetic
(drug effects)
- Transfection
- Tumor Cells, Cultured
- Vascular Endothelial Growth Factor A
- Vascular Endothelial Growth Factors
|